Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

RTranscode Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
R

Transcode Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • TransCode Therapeutics Announces Patent Advancements in Australia and Japan Strengthening Global IP Position in RNA-Based Immuno-Oncology
    Sep 22, 2026News Releases - TRANSCODE THERAPEUTICS, INC.
  • TransCode Therapeutics Announces Leadership Transition
    Sep 10, 2026News Releases - TRANSCODE THERAPEUTICS, INC.
  • TransCode Therapeutics Announces Publication Demonstrating Survival Benefit of TTX-MC138 in Preclinical Model of Breast Cancer Bone Metastasis
    Aug 31, 2026News Releases - TRANSCODE THERAPEUTICS, INC.
  • TransCode Therapeutics to Host R&D Webcast on June 18, 2026
    Jun 8, 2026News Releases - TRANSCODE THERAPEUTICS, INC.
  • TransCode Therapeutics Successfully Completes Phase 1a Clinical Trial, Reports Safety and Stabilization Data for TTX-MC138 in Metastatic Cancer
    Jun 3, 2026News Releases - TRANSCODE THERAPEUTICS, INC.
  • TransCode Therapeutics Initiates Phase 2a Clinical Trial with TTX-MC138 in Patients with ctDNA Positive Colorectal Cancer
    May 27, 2026News Releases - TRANSCODE THERAPEUTICS, INC.
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$1.77Close ยท Sep 22, 2026